RÉSUMÉ
Isolated perfused hearts from type 2 diabetic (db/db) mice show impaired ventricular function, as well as altered cardiac metabolism. Assessment of the relationship between myocardial oxygen consumption (MVO(2)) and ventricular pressure-volume area (PVA) has also demonstrated reduced cardiac efficiency in db/db hearts. We hypothesized that lowering the plasma fatty acid supply and subsequent normalization of altered cardiac metabolism by chronic treatment with a peroxisome proliferator-activated receptor-gamma (PPARgamma) agonist will improve cardiac efficiency in db/db hearts. Rosiglitazone (23 mg/kg body weight/day) was administered as a food admixture to db/db mice for five weeks. Ventricular function and PVA were assessed using a miniaturized (1.4 Fr) pressure-volume catheter; MVO(2) was measured using a fibre-optic oxygen sensor. Chronic rosiglitazone treatment of db/db mice normalized plasma glucose and lipid concentrations, restored rates of cardiac glucose and fatty acid oxidation, and improved cardiac efficiency. The improved cardiac efficiency was due to a significant decrease in unloaded MVO(2), while contractile efficiency was unchanged. Rosiglitazone treatment also improved functional recovery after low-flow ischemia. In conclusion, the present study demonstrates that in vivo PPARgamma-treatment restores cardiac efficiency and improves ventricular function in perfused hearts from type 2 diabetic mice.
Sujet(s)
Phénomènes physiologiques cardiovasculaires/effets des médicaments et des substances chimiques , Diabète de type 2/physiopathologie , Coeur/effets des médicaments et des substances chimiques , Thiazolidinediones/pharmacologie , Animaux , Glycémie/métabolisme , Poids/effets des médicaments et des substances chimiques , Vaisseaux coronaires/effets des médicaments et des substances chimiques , Diabète de type 2/traitement médicamenteux , Femelle , Coeur/physiologie , Coeur/physiopathologie , Canaux ioniques/métabolisme , Ischémie/physiopathologie , Métabolisme lipidique/effets des médicaments et des substances chimiques , Mâle , Souris , Souris de lignée C57BL , Protéines mitochondriales/métabolisme , Taille d'organe/effets des médicaments et des substances chimiques , Oxydoréduction/effets des médicaments et des substances chimiques , Consommation d'oxygène/effets des médicaments et des substances chimiques , ARN messager/génétique , ARN messager/métabolisme , Lésion d'ischémie-reperfusion , Rosiglitazone , Thiazolidinediones/usage thérapeutique , Protéine-3 de découplage , Fonction ventriculaire/effets des médicaments et des substances chimiquesRÉSUMÉ
AIM: The aim of the present study was to compare the coronary flow (CF) reserve of ex vivo perfused hearts from type 2 diabetic (db/db) and non-diabetic (db/+) mice. METHODS: The hearts were perfused in the Langendorff mode with Krebs-Henseleit bicarbonate buffer (37 degrees C, pH 7.4) containing 11 mmol L(-1) glucose as energy substrate. The coronary reserve was measured in response to three different interventions: (1) administration of nitroprusside (a nitric oxide donor), (2) administration of adenosine and (3) production of reactive hyperaemia by short-term ischaemia. RESULTS: Basal CF was approximately 15% lower in diabetic when compared with non-diabetic hearts (2.1 +/- 0.1 vs. 2.6 +/- 0.2 mL min(-1)). The maximum increase in CF rate in response to sodium nitroprusside and adenosine was significantly lower in diabetic (0.6 +/- 0.1 and 0.9 +/- 0.1 mL min(-1) respectively) than in non-diabetic hearts (1.2 +/- 0.1 and 1.4 +/- 0.1 mL min(-1) respectively). Also, there was a clear difference in the rate of return to basal CF following short-term ischaemia between diabetic and non-diabetic hearts. Thus, basal tone was restored 1-2 min after the peak hyperaemic response in non-diabetic hearts, whereas it took approximately 5 min in diabetic hearts. CONCLUSION: These results show that basal CF, as well as the CF reserve, is impaired in hearts from type 2 diabetic mice. As diabetic and non-diabetic hearts were exposed to the same (maximum) concentrations of NO or adenosine, it is suggested that the lower coronary reserve in type 2 diabetic hearts is, in part, because of a defect in the intracellular pathways mediating smooth muscle relaxation.
Sujet(s)
Circulation coronarienne , Diabète expérimental/physiopathologie , Diabète de type 2/physiopathologie , Ischémie myocardique/physiopathologie , Adénosine/pharmacologie , Animaux , Poids , Circulation coronarienne/effets des médicaments et des substances chimiques , Diabète expérimental/traitement médicamenteux , Diabète de type 2/traitement médicamenteux , Hypoglycémiants/usage thérapeutique , Acides lauriques/usage thérapeutique , Souris , Souris de lignée C57BL , Nitroprussiate/pharmacologie , Techniques de culture d'organes , Vasodilatateurs/pharmacologieRÉSUMÉ
Rewarming from accidental hypothermia is often complicated by "rewarming shock," characterized by low cardiac output (CO) and a sudden fall in peripheral arterial pressure. In this study, we tested whether epinephrine (Epi) is able to prevent rewarming shock when given intravenously during rewarming from experimental hypothermia in doses tested to elevate CO and induce vasodilation, or lack of vasodilation, during normothermia. A rat model designed for circulatory studies during experimental hypothermia and rewarming was used. A total of six groups of animals were used: normothermic groups 1, 2, and 3 for dose-finding studies, and hypothermic groups 4, 5, and 6. At 20 and 24 degrees C during rewarming, group 4 (low-dose Epi) and group 5 (high-dose Epi) received bolus injections of 0.1 and 1.0 microg Epi, respectively. At 28 degrees C, Epi infusion was started in groups 4 and 5 with 0.125 and 1.25 microg/min, respectively. Group 6 served as saline control. After rewarming, both CO and stroke volume were restored in group 4, in contrast to groups 5 and 6, in which both CO and stroke volume remained significantly reduced (30%). Total peripheral resistance was significantly higher in group 5 during rewarming from 24 to 34 degrees C, compared with groups 4 and 6. This study shows that, in contrast to normothermic conditions, Epi infused during hypothermia induces vasoconstriction rather than vasodilation combined with lack of CO elevation. The apparent dissociation between myocardial and vascular responses to Epi at low temperatures may be related to hypothermia-induced myocardial failure and changes in temperature-dependent adrenoreceptor affinity.
Sujet(s)
Épinéphrine/pharmacologie , Hypothermie provoquée , Réchauffement , Agonistes alpha-adrénergiques/administration et posologie , Agonistes alpha-adrénergiques/pharmacologie , Animaux , Température du corps , Débit cardiaque/effets des médicaments et des substances chimiques , Relation dose-effet des médicaments , Épinéphrine/administration et posologie , Perfusions veineuses , Mâle , Modèles animaux , Rats , Rat Wistar , Choc/physiopathologie , Choc/prévention et contrôle , Facteurs temps , Résistance vasculaire/effets des médicaments et des substances chimiques , Vasoconstriction/effets des médicaments et des substances chimiquesRÉSUMÉ
AIM: Langendorff-perfused murine hearts are increasingly used in cardiovascular research, but coronary cardiovascular haemodynamics vary considerably from one research group to another. The aim of this study was to establish an isolated, retrogradely perfused mouse heart preparation for the simultaneous measurement of left ventricular haemodynamics and of coronary flow (CF). METHODS: Heart rate was controlled by right atrial pacing (480 beats min(-1)) and heart temperature was kept constant. Accurate flow values of <0.5 mL min(-1) could be determined, and this methodology was then used to study the stability of this preparation, as well as coronary response to vasoactive drugs and to short-term ischaemia. RESULTS: The CF and maximum systolic pressure were well maintained over a 2-h perfusion period, both showing a 10% decline per hour. Sodium-nitroprusside (endothelium-independent) and adenosine (endothelium-dependent) increased CF relatively modest (30-50% above baseline values). Short-term no-flow ischaemia caused a transient 40-50% increase in CF on reperfusion. Peak reflow occurred approximately 15 s after start of reperfusion and flow returned to baseline during the following 1-2 min. Increased coronary blood flow following infusion of vasoactive drugs (nitroprusside or adenosine) or short-term ischaemia were associated with minor changes in ventricular pressure development. CONCLUSIONS: Blood flow and haemodynamics can readily be determined in this isolated perfused mouse heart model, but CF reserve is relatively small, compared with blood-perfused organs.